- Home
- YETI vs CRNX Comparison
YETI vs CRNX Comparison
Compare YETI & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YETI
- CRNX
- Stock Information
- Founded
- YETI 2006
- CRNX 2008
- Country
- YETI United States
- CRNX United States
- Employees
- YETI N/A
- CRNX N/A
- Industry
- YETI Recreational Games/Products/Toys
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- YETI Consumer Discretionary
- CRNX Health Care
- Exchange
- YETI Nasdaq
- CRNX Nasdaq
- Market Cap
- YETI 2.5B
- CRNX 2.8B
- IPO Year
- YETI 2018
- CRNX 2018
- Fundamental
- Price
- YETI $34.08
- CRNX $29.09
- Analyst Decision
- YETI Buy
- CRNX Strong Buy
- Analyst Count
- YETI 13
- CRNX 7
- Target Price
- YETI $38.67
- CRNX $74.33
- AVG Volume (30 Days)
- YETI 2.4M
- CRNX 939.3K
- Earning Date
- YETI 08-07-2025
- CRNX 08-07-2025
- Dividend Yield
- YETI N/A
- CRNX N/A
- EPS Growth
- YETI N/A
- CRNX N/A
- EPS
- YETI 2.10
- CRNX N/A
- Revenue
- YETI $1,822,000,000.00
- CRNX $1,392,000.00
- Revenue This Year
- YETI $4.93
- CRNX $409.34
- Revenue Next Year
- YETI $5.31
- CRNX $773.02
- P/E Ratio
- YETI $16.24
- CRNX N/A
- Revenue Growth
- YETI 3.63
- CRNX 0.51
- 52 Week Low
- YETI $26.61
- CRNX $24.10
- 52 Week High
- YETI $45.25
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- YETI 47.92
- CRNX 47.56
- Support Level
- YETI $33.50
- CRNX $25.83
- Resistance Level
- YETI $35.38
- CRNX $31.17
- Average True Range (ATR)
- YETI 1.51
- CRNX 1.31
- MACD
- YETI -0.26
- CRNX 0.17
- Stochastic Oscillator
- YETI 52.12
- CRNX 61.05
About YETI YETI Holdings Inc.
YETI Holdings Inc is a designer, marketer, and distributor of premium products for the outdoor and recreation market sold under the YETI brand. The company offers products including coolers and equipment, drinkware, and other accessories. Its trademark products include YETI Tundra, Hopper, YETI TANK, Rambler, Colster, Rambler among others. The company distributes products through wholesale channels and through direct-to-consumer, or DTC, channels.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.